Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma

Melanoma Research

Volumn 16, Issue 1, 2006, Pages 23-27

  Spugnini, Enrico P ^a,c   Dragonetti, Emanuele ^a   Vincenzi, Bruno ^a   Onori, Nicoletta ^a   Citro, Gennaro ^a   Baldi, Alfonso ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Biphasic pulses; Bleomycin; Electrochemotherapy; Melanoma; Oral

Indexed keywords

BLEOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG TOLERABILITY; HEAD AND NECK CARCINOMA; IMMUNE SYSTEM; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANIMAL DISEASE; DISEASE FREE SURVIVAL; DOG; DOG DISEASE; DRUG EFFECT; DRUG PULSE THERAPY; ELECTROPORATION; ELECTROSTIMULATION; FEMALE; MALE; METHODOLOGY; MORTALITY; MOUTH TUMOR; MUCOSA; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; BLEOMYCIN; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; ELECTRIC STIMULATION; ELECTROPORATION; FEMALE; MALE; MELANOMA; MOUTH NEOPLASMS; MUCOUS MEMBRANE; PULSE THERAPY, DRUG; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645454274     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000195702.73192.a0     Document Type: Article

References (36)

1. Andersen LJ, Berthelsen A, Hansen HS. Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol 1992; 21:180-185.
2. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: a review of the literature and report of 14 patients. Cancer 1997; 80:1373-1386.
3. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base Report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeon Commission on Cancer and the American Cancer Society. Cancer 1998; 83:1664-1678.
4. Lengyel E, Gilde K, Remenar E, Esik O. Malignant mucosal melanoma of the head and neck - a review. Pathol Oncol Res 2003; 9:7-12.
5. Umeda M, Shimada K. Primary malignant melanoma of the oral cavity - its histological classification and treatment. Br J Oral Maxillofac Surg 1994; 32:39-47.
6. Tanaka N, Amagasa T, Iwaki H, Shioda S, Takeda M, Ohashi K, Reck SF. Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol 1994; 78:81-90.
7. Perez CA, Chao KSC. Mucosal melanoma. In: Perez CA, Brady LW, editors. Principle and practice of radiation oncology. 3rd ed. Philadelphia, New York: Lippincott-Raven; 1997. pp. 1122-1123.
8. Chiu NT, Weinstock MA. Melanoma of the oronasal mucosa. Population-based analysis of occurrence and mortality. Arch Otolaryngol Head Neck Surg 1996; 122:985-988.
9. Asare-Owusu L, Shotton JC, Schofield JB. Adjuvant radiotherapy for primary mucosal malignant melanoma of the larynx. J Laryngol Otol 1999; 113:932-934.
10. Guzzo M, Grandi C, Licitra L, Podrecca S, Cascinelli N, Molinari R. Mucosal malignant melanoma of the head and neck; forty-eight cases treated at Instituto Nazionale Tumori of Milan. Eur J Surg Oncol 1993; 19:316-319.
11. Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, et al. Primary mucosal melanoma of the head and neck. Head Neck 2002; 24:247-257.
12. Barton RT. Mucosal melanomas of the head and neck. Laryngoscope 1975; 85:93-99.
13. Lund VJ, Howard DJ, Harding L, Wei WI. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999; 109:208-211.
14. Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope 1994; 104:121-126.
15. Trotti A, Peters LJ. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol 1993; 9:246-250.
16. Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003; 129:864-868.
17. Temam S, Mamelle G, Marandas P, Wibault P, Avril MF, Janot F, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005; 103:313-319.
18. Blatchford SJ, Koopman CF, Coulthard SW. Mucosal melanoma of the head and neck. Laryngoscope 1986; 96:929-934.
19. Withrow SJ. Cancer of the oral cavity. In: Withrow SJ, MacEwen EG, editors. Small animal clinical oncology. Philadelphia: WB. Saunders; 2001. pp. 305-317.
20. Rassnick KM, Ruslander DM, Cotter SM, Al-Sarraf R, Bruyette DS, Gamblin RM, et al. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000). J Am Vet Med Assoc 2001; 218:1444-1448.
21. MacEwen EG, Patnaik AK, Harvey HJ, Hayes AA, Matus R. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Invest 1986; 4:397-402.
22. Bateman KE, Catton PA, Pennock PW, Kruth SA. Radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med 1994; 8:267-272.
23. Blackwood L, Dobson JM. Radiotherapy of oral malignant melanoma in dogs. J Am Vet Med Assoc 1996; 209:98-102.
24. Daskalov I, Mudrov N, Peycheva E. Exploring new instrumentation parameters for electrochemotherapy. IEEE Eng Med Biol 1999; 18:62-66.
25. Spugnini EP, Porrello A. Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J Exp Clin Cancer Res 2003; 22:571-580.
26. Bergman PJ, McKnight J, Novosad A, Charney S, Farrelly J, Craft D, et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res 2003; 9:1284-1290.
27. Gyorffy S, Rodriguez-Lecompte JC, Woods JP, Foley R, Kruth S, Liaw PCY, et al. Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp 100 antigen. J Vet Intern Med 2005; 19:56-63.
28. Spugnini EP, Citro G, Porrello A. Rational design of new electrodes for electrochemotherapy. J Exp Clin Cancer Res 2005; 24:245-254.
29. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
30. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1-39.
31. Swinson BD, Witherow H, Amin M, Kalavrezos N, Newman L. Principles of management in oral cancer. Hosp Med 2003; 64:404-410.
32. Barasch A, Safford M, Eisenberg E. Oral cancer and oral effects of anticancer therapy. Mt Sinai J Med 1998; 65:370-377.
33. Schmidt-Ullrich RK, Johnson CR. Role of radiotherapy and hyperthermia in the management of malignant melanoma. Semin Surg Oncol 1996; 12:407-415.
34. Harwood AR. Melanomas of the head and neck. J Otolaryngol 1983; 12:64-69.
35. Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope 1994; 104:121-126.
36. Ballo MT, Ang KK. Radiation therapy for malignant melanoma. Surg Clin North Am 2003; 83:323-342.